Testosterone pellet implants and migraine headaches: A pilot study

Glaser R et al. – Continuous testosterone was effective therapy in reducing the severity of migraine headaches in both pre– and post–menopausal women.

Methods

• Twenty–seven women with a history of documented migraine headache were asked to rate their headache severity using a five–point scale at baseline (prior to therapy); and again, 3months following treatment with testosterone implants. Improvement in headache severity was noted by 92% of patients and the mean level of improvement was statistically significant (3.3 on a 5 point scale).
• Improvement in headache severity was noted by 92% of patients and the mean level of improvement was statistically significant (3.3 on a 5 point scale).

Results

• There was no difference in the level of improvement between pre– and post–menopausal cohorts.
• Seventy–four percent of patients reported a headache severity score of ‘0’ (none) on testosterone implant therapy for the 3–month treatment period.

[more...]